New technologies and strategic partnerships are rewriting the rules of business in biotech, biomedical engineering and medical device design. Profitability is rising, yet the industry is expected to remain mired in unremitting, long-standing regulatory and financial pressures.
The role of counsel in assisting and defending researchers, designers, manufacturers and vendors of drugs and devices remains critical for clients ranging from start-ups to Fortune 500 companies. Our strategies are tailored to the individual needs of each client, with an emphasis on efficiency and cost-effective use of resources.
The size and depth of our team allows us to represent clients from coast-to-coast of all sizes, from individual "garage" inventors to medical "start-ups," and large corporations.